Valeant Pharmaceuticals International (VRX) Stock Price, News & Analysis

VRX

Company Description

This page collects what Stock Titan holds for VRX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—

-

-

Last updated:

-

Performance 1 year

-

-

Shares outstanding

Latest News

April 13, 2021

—

Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction

clinical trial

February 24, 2021

—

Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2020 Results And Provides 2021 Guidance

earnings

January 20, 2021

—

Bausch + Lomb Announces Scientific Data On Bausch + Lomb INFUSE™ Silicone Hydrogel Daily Disposable Contact Lenses To Be Presented At The Virtual Global Specialty Lens Symposium

October 27, 2020

—

Bausch + Lomb Introduces SimplifEYE™ IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses

October 22, 2020

—

Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting

conferences

September 23, 2020

—

Bausch Health Releases Annual Corporate Social Responsibility Report

Valeant Pharmaceuticals International has 8 recent news articles. Key topics include clinical trial, earnings, conferences. View all VRX news →

SEC Filings

No SEC filings available for VRX.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months